Trial site
Stronach Regional Health Centre at Southlake
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Chronic lymphocytic leukaemia2 trials
- Colorectal cancer2 trials
- Bladder cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Obesity1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 2/32 trials
- Status
- Active, not recruiting7 trials
- Completed4 trials
- Recruiting3 trials
- Lead sponsor
- Canadian Cancer Trials Group8 trials
- National Cancer Institute (NCI)2 trials
- NRG Oncology2 trials
- Alliance for Clinical Trials in Oncology1 trial
- Radiation Therapy Oncology Group1 trial
Running trials
Recruiting
Recruiting
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Active, not recruiting
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Active, not recruiting
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
Completed
Completed
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026